UMEM Educational Pearls

Settings: Secondary analysis of the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial.

Participants:

1368 patients who survived on day 28 after enrollment, and were retrospectively assigned different subtypes:

  1. Low risk, barriers to care. Younger patients with few comorbidities, less severe disease, 

  2. Unhealthy baseline with severe illness: Previously healthy with severe illness and complex needs after discharge, barriers to care.

  3. Multimorbidity. Older patients with more comorbidities and are frequently readmitted. 

  4. Low functional status: Poor functional status. Older patients with high prevalence of frailty at discharge and high functional needs who are  often discharged to a facility.

  5. Unhealthy baseline with severe illness: Existing poor health with severe illness and complex needs  after discharge. Older patients with severe comorbidities,  more severe illness, high functional needs, prolonged hospital stay, 

Outcome measurement

A) 90-day mortality, 

B) 6-month and 12-month EuroQol 5D five level score

Study Results:

A) 90-day mortality:

Unhealthy baseline  with severe illness (37.6%) >  low functional status (45.5%) > multimorbidity (17.4%) >  unhealthy baseline, severe illness (13.2%) > Low risk (5.1%).

B) 6-month EuroQol 5D-Five Level: lower score, lower functional outcomes)

Unhealthy baseline  with severe illness (0.53) >  unhealthy baseline, severe illness (0.68) > low functional status (0.69) > multimorbidity (0.78) >  Low risk (0.80).

Discussion:

a) The framework, readily available to clinicians provides good prognostic tools for mortality.

b) Although there was prediction of poor functional outcomes at 6-month and 12-month, the differences between subtypes in their EuroQoL 5D-5L did not seem to correspond to 90-day mortality. Low functional status group had 2nd-highest rate of mortality, but only 3rd in their EuroQoL 5D-3L score. Thus, there needs to be more studies in these nuances.

Conclusion

Sepsis survivor subtypes—assigned using only three routinely available discharge variables—are strongly associated with 3-month mortality and long-term disability and HRQOL up to 12 months

References

Flick RJ, Kamphuis LA, Valley TS, Armstrong-Hough M, Iwashyna TJ. Association of Sepsis Survivor Subtypes With Long-Term Mortality and Disability After Discharge: A Retrospective Cohort Study. Crit Care Med. 2026 Jan 1;54(1):45-54. doi: 10.1097/CCM.0000000000006933. Epub 2025 Nov 13. PMID: 41231072.

Attachments